Abstract

Sensory ganglionopathies (SG) may occur in association with different diseases and are characterized by the degeneration of the primary sensory neurons located in the dorsal root ganglia. The most important associated conditions are paraneoplastic SG, HIV infection, Sjogren's syndrome, and cisplatin or pyridoxine toxicity. Even when clinical criteria help differentiate SG from other neuropathies, an etiological diagnosis remains elusive. Thus, there is a need to identify biological markers than can distinguish immune-mediated SG from other etiologies. Objectives: The present study of two cases of SG compares their neurological outcomes with their treatment responses in accordance with the etiology of each one. Methods: evaluate the clinical presentation and examination results to be able to define the etiology and institute early treatment. Results: To differentiate paraneoplastic and idiopathic causes, more precise imaging techniques and paraneoplastic antibody tests are required. These diagnostic tools might be helpful in early diagnosis and treatment, thus affording the best chance of stabilizing the neurological symptoms. Conclusions: The identification of paraneoplastic antibodies before the onset of cancer can reduce the percentage of cases misdiagnosed as idiopathic, leading to early treatment and perhaps a more favorable prognosis.

Highlights

  • Sensory ganglionopathies (SG), characterized by the degeneration of the primary sensory neurons located in the dorsal root ganglia, may occur in association with different diseases [1]

  • The present study examines two cases of SG by comparing and highlighting the importance of the clinical presentation and laboratory results mainly from the perspective of the presence of paraneoplastic antibodies in the management of patients

  • Sjogren's syndrome (SS) is the most frequent immune-mediated disease related to SG [2]

Read more

Summary

Open Access

Paraneoplastic and Idiopathic Ganglionopathy: Importance of Differential Diagnosis. Guilherme Perassa Gasque*, Felipe da Rocha Schmidt, Diogo Matheus Terrana de Carvalho, Salim Balassiano, José Marcelo Ferreira Bezerra and Marcia Rodrigues Jardim. Received date: Nov 10, 2015; Accepted date: Dec 11, 2015; Published date: Dec 18, 2015

Introduction
Sensory standard
Paraneoplastic antibodies Pet Scan
Findings
Discussion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.